Corporate NANOTECHNOLOGY

Research and investor interest in nanotechnology is soaring and nanotechnology funding is on the rise. Our corporate lawyers have the breadth and depth of experience to serve nanotechnology clients in all aspects of corporate growth. We are widely recognized for our preeminence in the representation of entrepreneurs, technology and life sciences companies, our experience in securities and other regulatory matters of critical importance to corporate clients, and our leadership in initial public offerings, venture capital, strategic alliances, corporate governance matters and the representation of startup companies.

We have wide-ranging experience representing emerging companies, industry leaders and major investment banks in public offerings of equity and debt securities in US and international markets. Since 2004, we have served as counsel in more than 400 public offerings and Rule 144A placements raising nearly $150 billion.

We also have a significant presence in the venture capital community throughout the US and Europe. Since 2004, we have handled more than 2,200 venture financings raising approximately $20 billion. We are counsel to more venture-backed companies in the eastern half of the U.S. than any other law firm. Among other services, we help startups structure venture investments, license core technology and design equity incentive plans. We also routinely advise university spin-out companies launched from renowned research institutions in the United States and Europe.

Many business models include the acquisition of key technologies, and nanotechnology is no exception. We have decades of experience advising public and private companies in all aspects of mergers and acquisitions in both the United States and Europe. Since 2004, we have participated in more than 1,000 mergers and acquisitions with a total value in excess of $350 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers. Our experience ranges from public-public mergers and the related Securities and Exchange Commission, disclosure and fiduciary duty issues to the unique issues presented by sales of VC-backed private companies. We also advise clients on friendly and hostile tender offers, and represent investment banks serving as financial advisors in mergers.

Research and investor interest in nanotechnology is soaring and nanotechnology funding is on the rise. Our corporate lawyers have the breadth and depth of experience to serve nanotechnology clients in all aspects of corporate growth. We are widely recognized for our preeminence in the representation of entrepreneurs, technology and life sciences companies, our experience in securities and other regulatory matters of critical importance to corporate clients, and our leadership in initial public offerings, venture capital, strategic alliances, corporate governance matters and the representation of startup companies.

We have wide-ranging experience representing emerging companies, industry leaders and major investment banks in public offerings of equity and debt securities in US and international markets. Since 2004, we have served as counsel in more than 400 public offerings and Rule 144A placements raising nearly $150 billion.

Read More

Publications & News

View

December 14, 2016

WilmerHale Reps Nantero in $21M Financing for Carbon Nanotube Computer Memory

The WilmerHale deal team was led by Partner Jay Bothwick and included Senior Associate Jenna Ventorino and Associate Alyce Chen.

March 1, 2008

Selected 2007 Information Technology Transactions

WilmerHale provides solutions to the challenges facing companies at all stages of growth in industries as diverse as enterprise software, semiconductors, nanotechnology, e-commerce, telecommunications, financial services, biotechnology and business process outsourcing. For over four decades, we have represented our clients in licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; patent prosecution and portfolio development; and corporate finance and liquidity transactions.

November 1, 2006

WilmerHale Presents the 2006 Compensation and Entrepreneurship Report in Information Technology and the 2006 Compensation and Entrepreneurship Report in Life Sciences

January 1, 2006

The five elements of establishing solid nanotech intellectual property

An article by Mary Rose Scozzafava published in Mass High Tech, Volume 24, Issue 2.

January 1, 2006

Whither nanotech? Legal issues still in play for this emerging field

An article by Peter Dichiara and David Abrams published in Mass High Tech, Volume 17, Issue 2.